FindTrial
Sign In

The clinical application of ultrasound-guided serratus anterior plane block combined with transverse thoracic muscle plane block in radical mastectomy

The clinical application of ultrasound-guided serratus anterior plane block combined with transverse thoracic muscle plane block in radical mastectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021874
Enrollment
Unknown
Registered
2019-03-14
Start date
2019-03-12
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group S:serratus anterior block
Group ST:serratus anterior block and transverse thoracic muscle plane block

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Aged 18 to 60 years; ? ASA grade I to II; ? Can volunteer to cooperate with this research; ? Modified elective breast cancer modified radical resection.

Exclusion criteria

Exclusion criteria: ? There are contraindications for serratus anterior plane block and transverse thoracic muscle plane block: severe abnormal blood coagulation, infection at puncture site, etc.. ? Long-term use of sedative drugs or anti-depression and other psychotropic drugs. ? Taking other experimental drugs or participating in other clinical trials within 3 months before enrolling in the study. ? Received radiotherapy or chemotherapy before surgery. ? Chronic chronic pain history, long-term use of painkillers.

Design outcomes

Primary

MeasureTime frame
QoR-15 score 24 hours after surgery;—

Countries

China

Contacts

Public ContactJia Mengxing
dxj780324@163.com+86 15895238016

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026